Biovail Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 757.2 | 842.8 | 1,070.5 |
| Cost of Goods Sold | 197.2 | 221.9 | 223.3 |
| Gross Profit | 560.0 | 620.9 | 847.2 |
| Gross Profit Margin | 74.0% | 73.7% | 79.1% |
| SG&A Expense | 188.9 | 161.0 | 238.4 |
| Depreciation & Amortization | 51.4 | 48.0 | 56.5 |
| Operating Income | 127.9 | 218.5 | 257.5 |
| Operating Margin | 16.9% | 25.9% | 24.1% |
| Nonoperating Income | (5.6) | 2.9 | (7.2) |
| Nonoperating Expenses | 8.4 | -- | -- |
| Income Before Taxes | 126.9 | 208.7 | 222.3 |
| Income Taxes | (73.0) | 13.2 | 14.5 |
| Net Income After Taxes | 199.9 | 195.5 | 207.8 |
| Continuing Operations | 199.9 | 195.5 | 207.8 |
| Discontinued Operations | 0.0 | 0.0 | (3.8) |
| Total Operations | 199.9 | 195.5 | 203.9 |
| Total Net Income | 199.9 | 195.5 | 203.9 |
| Net Profit Margin | 26.4% | 23.2% | 19.1% |
| Diluted EPS from Total Net Income ($) | 1.25 | 1.22 | 1.27 |
| Dividends per Share | 1.50 | 1.50 | 0.50 |
© 2009 Morningstar, Inc. Financial Data provided by
